Reference
New warning on the risk of depression and related events associated with Kalydeco, Orkambi, Symkevi and Kaftrio HPRA Drug Safety Newsletter : No. 115, 26 Apr 2024. Available from: URL: https://www.hpra.ie/docs/default-source/publications-forms/newsletters/hpra-drug-safety-newsletter-edition-115.pdf?sfvrsn=5
Rights and permissions
About this article
Cite this article
Warning on depression and suicidal ideation with cystic fibrosis medicines. Reactions Weekly 2007, 9 (2024). https://doi.org/10.1007/s40278-024-58569-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-58569-z